https://pmc.ncbi.nlm.nih.gov/articles/PMC8210042/
Activity of novel lactone ketolide nafithromycin against multicentric invasive and non-invasive...
India is among the nations reporting substantial healthcare burden linked to pneumococcal infections. Nafithromycin is a novel lactone ketolide antibiotic,...
activitynovellactone
https://pubmed.ncbi.nlm.nih.gov/40833448/
Novel Macrolide Antibiotic Nafithromycin for Tackling Emerging Resistance in Respiratory Pathogens...
Nafithromycin (WCK 4873), is India's first approved macrolide antibiotic by DCGI(Drug Controller General of India), represents a significant advancement in...
macrolide antibioticnovel